Loading
Latest filing published 21 Jan 2022 for Algernon Pharmaceuticals Inc..
No signal scores available.
David Levine appears in our data through filings on Algernon Pharmaceuticals Inc. shares, published by SEDI. Over a trading history stretching from 2 February 2021 to 23 November 2021, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 21 January 2022 came the latest disclosure, a transaction in Algernon Pharmaceuticals Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations